1. Home
  2. NBIX vs PR Comparison

NBIX vs PR Comparison

Compare NBIX & PR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$174.19

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Permian Resources Corporation

PR

Permian Resources Corporation

HOLD

Current Price

$18.20

Market Cap

15.2B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
PR
Founded
1992
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
15.2B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
NBIX
PR
Price
$174.19
$18.20
Analyst Decision
Strong Buy
Buy
Analyst Count
22
19
Target Price
$180.91
$22.35
AVG Volume (30 Days)
1.1M
11.5M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
N/A
2.96%
EPS Growth
41.95
N/A
EPS
1.91
0.05
Revenue
$161,626,000.00
$5,065,211,000.00
Revenue This Year
$24.73
$20.94
Revenue Next Year
$13.14
$7.51
P/E Ratio
$91.24
$364.00
Revenue Growth
977.51
1.29
52 Week Low
$122.14
$11.92
52 Week High
$174.38
$22.68

Technical Indicators

Market Signals
Indicator
NBIX
PR
Relative Strength Index (RSI) 67.99 38.75
Support Level $153.96 $18.04
Resistance Level N/A $19.39
Average True Range (ATR) 4.48 0.46
MACD 0.66 -0.04
Stochastic Oscillator 95.56 17.11

Price Performance

Historical Comparison
NBIX
PR

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About PR Permian Resources Corporation

Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization, and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.

Share on Social Networks: